nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vinblastine—testicular cancer	0.298	1	CiPCiCtD
Vinorelbine—Vinblastine—testicular cancer	0.225	1	CrCtD
Vinorelbine—ovarian cancer—testicular cancer	0.0913	0.553	CtDrD
Vinorelbine—lung cancer—testicular cancer	0.0737	0.447	CtDrD
Vinorelbine—Vincristine—Vinblastine—testicular cancer	0.0528	0.379	CrCrCtD
Vinorelbine—Vindesine—Vinblastine—testicular cancer	0.0528	0.379	CrCrCtD
Vinorelbine—Voacamine—Vinblastine—testicular cancer	0.0337	0.242	CrCrCtD
Vinorelbine—TUBB4A—Vinblastine—testicular cancer	0.0147	0.11	CbGbCtD
Vinorelbine—TUBB8—Vinblastine—testicular cancer	0.0147	0.11	CbGbCtD
Vinorelbine—TUBB6—Vinblastine—testicular cancer	0.0147	0.11	CbGbCtD
Vinorelbine—TUBB2A—Vinblastine—testicular cancer	0.0147	0.11	CbGbCtD
Vinorelbine—TUBB3—Vinblastine—testicular cancer	0.0147	0.11	CbGbCtD
Vinorelbine—TUBB2B—Vinblastine—testicular cancer	0.0147	0.11	CbGbCtD
Vinorelbine—TUBB—Vinblastine—testicular cancer	0.0123	0.092	CbGbCtD
Vinorelbine—TUBB4B—Vinblastine—testicular cancer	0.0123	0.092	CbGbCtD
Vinorelbine—TUBB1—Vinblastine—testicular cancer	0.0123	0.092	CbGbCtD
Vinorelbine—ABCB1—Dactinomycin—testicular cancer	0.0014	0.0105	CbGbCtD
Vinorelbine—CYP3A4—Ifosfamide—testicular cancer	0.000991	0.0074	CbGbCtD
Vinorelbine—ABCB1—Vinblastine—testicular cancer	0.000878	0.00655	CbGbCtD
Vinorelbine—CYP2D6—Vinblastine—testicular cancer	0.000827	0.00617	CbGbCtD
Vinorelbine—ABCB1—Cisplatin—testicular cancer	0.000805	0.006	CbGbCtD
Vinorelbine—ABCB1—Etoposide—testicular cancer	0.000791	0.0059	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—testicular cancer	0.000539	0.00402	CbGbCtD
Vinorelbine—CYP3A4—Vinblastine—testicular cancer	0.000526	0.00392	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—testicular cancer	0.000522	0.0039	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—testicular cancer	0.000508	0.00379	CbGbCtD
Vinorelbine—CYP3A4—Etoposide—testicular cancer	0.000474	0.00353	CbGbCtD
Vinorelbine—TUBB8—testis—testicular cancer	0.000376	0.0587	CbGeAlD
Vinorelbine—CYP3A4—Doxorubicin—testicular cancer	0.000323	0.00241	CbGbCtD
Vinorelbine—TUBB4A—embryo—testicular cancer	0.000319	0.0498	CbGeAlD
Vinorelbine—TUBB2B—seminal vesicle—testicular cancer	0.00029	0.0452	CbGeAlD
Vinorelbine—TUBB—seminal vesicle—testicular cancer	0.000274	0.0428	CbGeAlD
Vinorelbine—TUBB2A—seminal vesicle—testicular cancer	0.000273	0.0425	CbGeAlD
Vinorelbine—TUBB6—seminal vesicle—testicular cancer	0.000269	0.042	CbGeAlD
Vinorelbine—TUBB3—testis—testicular cancer	0.000257	0.04	CbGeAlD
Vinorelbine—TUBB1—testis—testicular cancer	0.000251	0.0391	CbGeAlD
Vinorelbine—TUBB4B—embryo—testicular cancer	0.000249	0.0388	CbGeAlD
Vinorelbine—TUBB4B—seminal vesicle—testicular cancer	0.000234	0.0365	CbGeAlD
Vinorelbine—TUBB4A—gonad—testicular cancer	0.000217	0.0338	CbGeAlD
Vinorelbine—TUBB2B—gonad—testicular cancer	0.00021	0.0327	CbGeAlD
Vinorelbine—TUBB6—gonad—testicular cancer	0.000195	0.0303	CbGeAlD
Vinorelbine—TUBB4A—female gonad—testicular cancer	0.000176	0.0275	CbGeAlD
Vinorelbine—TUBB2B—female gonad—testicular cancer	0.00017	0.0265	CbGeAlD
Vinorelbine—TUBB4B—gonad—testicular cancer	0.000169	0.0264	CbGeAlD
Vinorelbine—TUBB—female gonad—testicular cancer	0.000161	0.0251	CbGeAlD
Vinorelbine—TUBB2A—female gonad—testicular cancer	0.00016	0.025	CbGeAlD
Vinorelbine—TUBB6—female gonad—testicular cancer	0.000158	0.0246	CbGeAlD
Vinorelbine—TUBB4A—testis—testicular cancer	0.000156	0.0244	CbGeAlD
Vinorelbine—TUBB2B—testis—testicular cancer	0.000151	0.0235	CbGeAlD
Vinorelbine—TUBB—testis—testicular cancer	0.000143	0.0223	CbGeAlD
Vinorelbine—TUBB2A—testis—testicular cancer	0.000142	0.0222	CbGeAlD
Vinorelbine—TUBB6—testis—testicular cancer	0.00014	0.0219	CbGeAlD
Vinorelbine—TUBB4B—female gonad—testicular cancer	0.000137	0.0214	CbGeAlD
Vinorelbine—TUBB4B—testis—testicular cancer	0.000122	0.019	CbGeAlD
Vinorelbine—TUBB4A—lymph node—testicular cancer	0.000113	0.0177	CbGeAlD
Vinorelbine—TUBB2B—lymph node—testicular cancer	0.000109	0.0171	CbGeAlD
Vinorelbine—TUBB—lymph node—testicular cancer	0.000104	0.0161	CbGeAlD
Vinorelbine—TUBB2A—lymph node—testicular cancer	0.000103	0.0161	CbGeAlD
Vinorelbine—TUBB6—lymph node—testicular cancer	0.000102	0.0158	CbGeAlD
Vinorelbine—TUBB4B—lymph node—testicular cancer	8.83e-05	0.0138	CbGeAlD
Vinorelbine—ABCB1—embryo—testicular cancer	7.25e-05	0.0113	CbGeAlD
Vinorelbine—ABCB1—seminal vesicle—testicular cancer	6.81e-05	0.0106	CbGeAlD
Vinorelbine—CYP2D6—female gonad—testicular cancer	5.56e-05	0.00866	CbGeAlD
Vinorelbine—CYP2D6—testis—testicular cancer	4.93e-05	0.00768	CbGeAlD
Vinorelbine—ABCB1—gonad—testicular cancer	4.92e-05	0.00767	CbGeAlD
Vinorelbine—ABCB1—female gonad—testicular cancer	4e-05	0.00623	CbGeAlD
Vinorelbine—ABCB1—testis—testicular cancer	3.54e-05	0.00553	CbGeAlD
Vinorelbine—ABCB1—lymph node—testicular cancer	2.57e-05	0.00401	CbGeAlD
Vinorelbine—Thrombocytopenia—Etoposide—testicular cancer	1.79e-05	0.000565	CcSEcCtD
Vinorelbine—Tachycardia—Etoposide—testicular cancer	1.79e-05	0.000563	CcSEcCtD
Vinorelbine—Dyspnoea—Cisplatin—testicular cancer	1.78e-05	0.000562	CcSEcCtD
Vinorelbine—Skin disorder—Etoposide—testicular cancer	1.78e-05	0.000561	CcSEcCtD
Vinorelbine—Pancreatitis—Epirubicin—testicular cancer	1.77e-05	0.000558	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—testicular cancer	1.76e-05	0.000554	CcSEcCtD
Vinorelbine—Anorexia—Etoposide—testicular cancer	1.74e-05	0.00055	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	1.74e-05	0.000548	CcSEcCtD
Vinorelbine—Decreased appetite—Cisplatin—testicular cancer	1.74e-05	0.000548	CcSEcCtD
Vinorelbine—Diarrhoea—Dactinomycin—testicular cancer	1.73e-05	0.000546	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—testicular cancer	1.73e-05	0.000545	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Cisplatin—testicular cancer	1.72e-05	0.000544	CcSEcCtD
Vinorelbine—Vomiting—Bleomycin—testicular cancer	1.72e-05	0.000544	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—testicular cancer	1.72e-05	0.000542	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—testicular cancer	1.72e-05	0.000542	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—testicular cancer	1.71e-05	0.00054	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—testicular cancer	1.71e-05	0.000539	CcSEcCtD
Vinorelbine—Rash—Bleomycin—testicular cancer	1.71e-05	0.000539	CcSEcCtD
Vinorelbine—Pain—Cisplatin—testicular cancer	1.71e-05	0.000539	CcSEcCtD
Vinorelbine—Dermatitis—Bleomycin—testicular cancer	1.71e-05	0.000539	CcSEcCtD
Vinorelbine—Hypersensitivity—Ifosfamide—testicular cancer	1.71e-05	0.000538	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—testicular cancer	1.7e-05	0.000537	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—testicular cancer	1.69e-05	0.000532	CcSEcCtD
Vinorelbine—Stomatitis—Methotrexate—testicular cancer	1.68e-05	0.000528	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—testicular cancer	1.67e-05	0.000526	CcSEcCtD
Vinorelbine—Asthenia—Ifosfamide—testicular cancer	1.66e-05	0.000524	CcSEcCtD
Vinorelbine—Feeling abnormal—Cisplatin—testicular cancer	1.65e-05	0.000519	CcSEcCtD
Vinorelbine—Paraesthesia—Etoposide—testicular cancer	1.64e-05	0.000518	CcSEcCtD
Vinorelbine—Pruritus—Ifosfamide—testicular cancer	1.64e-05	0.000517	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—testicular cancer	1.64e-05	0.000516	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—testicular cancer	1.63e-05	0.000515	CcSEcCtD
Vinorelbine—Dyspnoea—Etoposide—testicular cancer	1.63e-05	0.000515	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—testicular cancer	1.63e-05	0.000513	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—testicular cancer	1.63e-05	0.000513	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—testicular cancer	1.62e-05	0.00051	CcSEcCtD
Vinorelbine—Nausea—Bleomycin—testicular cancer	1.61e-05	0.000508	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—testicular cancer	1.61e-05	0.000507	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—testicular cancer	1.61e-05	0.000507	CcSEcCtD
Vinorelbine—Vomiting—Dactinomycin—testicular cancer	1.61e-05	0.000507	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—testicular cancer	1.6e-05	0.000506	CcSEcCtD
Vinorelbine—Rash—Dactinomycin—testicular cancer	1.59e-05	0.000503	CcSEcCtD
Vinorelbine—Decreased appetite—Etoposide—testicular cancer	1.59e-05	0.000502	CcSEcCtD
Vinorelbine—Diarrhoea—Ifosfamide—testicular cancer	1.59e-05	0.0005	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—testicular cancer	1.59e-05	0.0005	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—testicular cancer	1.58e-05	0.000498	CcSEcCtD
Vinorelbine—Body temperature increased—Cisplatin—testicular cancer	1.58e-05	0.000498	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—testicular cancer	1.58e-05	0.000498	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—testicular cancer	1.58e-05	0.000497	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—testicular cancer	1.57e-05	0.000494	CcSEcCtD
Vinorelbine—Constipation—Etoposide—testicular cancer	1.57e-05	0.000494	CcSEcCtD
Vinorelbine—Pain—Etoposide—testicular cancer	1.57e-05	0.000494	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—testicular cancer	1.56e-05	0.000492	CcSEcCtD
Vinorelbine—Dizziness—Ifosfamide—testicular cancer	1.53e-05	0.000483	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—testicular cancer	1.52e-05	0.00048	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—testicular cancer	1.51e-05	0.000476	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—testicular cancer	1.51e-05	0.000476	CcSEcCtD
Vinorelbine—Nausea—Dactinomycin—testicular cancer	1.5e-05	0.000474	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—testicular cancer	1.5e-05	0.000473	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—testicular cancer	1.5e-05	0.000472	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—testicular cancer	1.5e-05	0.000472	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—testicular cancer	1.49e-05	0.000469	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—testicular cancer	1.49e-05	0.000469	CcSEcCtD
Vinorelbine—Vomiting—Ifosfamide—testicular cancer	1.47e-05	0.000465	CcSEcCtD
Vinorelbine—Hypersensitivity—Cisplatin—testicular cancer	1.47e-05	0.000464	CcSEcCtD
Vinorelbine—Rash—Ifosfamide—testicular cancer	1.46e-05	0.000461	CcSEcCtD
Vinorelbine—Dermatitis—Ifosfamide—testicular cancer	1.46e-05	0.00046	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—testicular cancer	1.46e-05	0.00046	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—testicular cancer	1.45e-05	0.000458	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—testicular cancer	1.45e-05	0.000457	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—testicular cancer	1.45e-05	0.000456	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—testicular cancer	1.45e-05	0.000456	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—testicular cancer	1.44e-05	0.000453	CcSEcCtD
Vinorelbine—Asthenia—Cisplatin—testicular cancer	1.43e-05	0.000452	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—testicular cancer	1.43e-05	0.000452	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—testicular cancer	1.42e-05	0.000447	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—testicular cancer	1.41e-05	0.000444	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—testicular cancer	1.4e-05	0.000441	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—testicular cancer	1.39e-05	0.000439	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—testicular cancer	1.39e-05	0.000438	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—testicular cancer	1.39e-05	0.000438	CcSEcCtD
Vinorelbine—Nausea—Ifosfamide—testicular cancer	1.38e-05	0.000434	CcSEcCtD
Vinorelbine—Diarrhoea—Cisplatin—testicular cancer	1.37e-05	0.000431	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—testicular cancer	1.36e-05	0.00043	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—testicular cancer	1.35e-05	0.000425	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—testicular cancer	1.34e-05	0.000424	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—testicular cancer	1.34e-05	0.000424	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—testicular cancer	1.34e-05	0.000423	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—testicular cancer	1.34e-05	0.000423	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—testicular cancer	1.33e-05	0.000419	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—testicular cancer	1.31e-05	0.000414	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—testicular cancer	1.31e-05	0.000414	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—testicular cancer	1.31e-05	0.000413	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—testicular cancer	1.3e-05	0.000411	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—testicular cancer	1.3e-05	0.00041	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—testicular cancer	1.3e-05	0.00041	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—testicular cancer	1.29e-05	0.000408	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—testicular cancer	1.29e-05	0.000407	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—testicular cancer	1.28e-05	0.000402	CcSEcCtD
Vinorelbine—Vomiting—Cisplatin—testicular cancer	1.27e-05	0.000401	CcSEcCtD
Vinorelbine—Rash—Cisplatin—testicular cancer	1.26e-05	0.000397	CcSEcCtD
Vinorelbine—Dermatitis—Cisplatin—testicular cancer	1.26e-05	0.000397	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—testicular cancer	1.26e-05	0.000396	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—testicular cancer	1.26e-05	0.000396	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—testicular cancer	1.25e-05	0.000395	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—testicular cancer	1.25e-05	0.000393	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—testicular cancer	1.24e-05	0.000391	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—testicular cancer	1.24e-05	0.000391	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—testicular cancer	1.24e-05	0.000391	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—testicular cancer	1.22e-05	0.000383	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—testicular cancer	1.21e-05	0.000382	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—testicular cancer	1.21e-05	0.000382	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—testicular cancer	1.21e-05	0.000382	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—testicular cancer	1.21e-05	0.000381	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—testicular cancer	1.21e-05	0.000381	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—testicular cancer	1.2e-05	0.00038	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—testicular cancer	1.2e-05	0.000379	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—testicular cancer	1.19e-05	0.000376	CcSEcCtD
Vinorelbine—Nausea—Cisplatin—testicular cancer	1.19e-05	0.000374	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—testicular cancer	1.18e-05	0.000372	CcSEcCtD
Vinorelbine—Cough—Methotrexate—testicular cancer	1.17e-05	0.00037	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—testicular cancer	1.17e-05	0.000368	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—testicular cancer	1.16e-05	0.000367	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—testicular cancer	1.16e-05	0.000367	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—testicular cancer	1.16e-05	0.000367	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—testicular cancer	1.16e-05	0.000366	CcSEcCtD
Vinorelbine—Rash—Etoposide—testicular cancer	1.15e-05	0.000364	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—testicular cancer	1.15e-05	0.000364	CcSEcCtD
Vinorelbine—Headache—Etoposide—testicular cancer	1.15e-05	0.000362	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—testicular cancer	1.14e-05	0.000361	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—testicular cancer	1.14e-05	0.000361	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—testicular cancer	1.14e-05	0.000361	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	1.14e-05	0.000358	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—testicular cancer	1.13e-05	0.000357	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—testicular cancer	1.13e-05	0.000356	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—testicular cancer	1.13e-05	0.000356	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—testicular cancer	1.13e-05	0.000355	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—testicular cancer	1.13e-05	0.000355	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—testicular cancer	1.11e-05	0.00035	CcSEcCtD
Vinorelbine—Cough—Epirubicin—testicular cancer	1.1e-05	0.000346	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—testicular cancer	1.1e-05	0.000346	CcSEcCtD
Vinorelbine—Infection—Methotrexate—testicular cancer	1.09e-05	0.000343	CcSEcCtD
Vinorelbine—Nausea—Etoposide—testicular cancer	1.09e-05	0.000343	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—testicular cancer	1.09e-05	0.000342	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—testicular cancer	1.08e-05	0.00034	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—testicular cancer	1.08e-05	0.000339	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—testicular cancer	1.08e-05	0.000339	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—testicular cancer	1.07e-05	0.000338	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—testicular cancer	1.07e-05	0.000337	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—testicular cancer	1.07e-05	0.000337	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—testicular cancer	1.07e-05	0.000337	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—testicular cancer	1.06e-05	0.000336	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	1.06e-05	0.000335	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—testicular cancer	1.06e-05	0.000333	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—testicular cancer	1.05e-05	0.000331	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—testicular cancer	1.05e-05	0.00033	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—testicular cancer	1.05e-05	0.000329	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—testicular cancer	1.04e-05	0.000328	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—testicular cancer	1.03e-05	0.000324	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—testicular cancer	1.03e-05	0.000323	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—testicular cancer	1.02e-05	0.000323	CcSEcCtD
Vinorelbine—Infection—Epirubicin—testicular cancer	1.02e-05	0.000321	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—testicular cancer	1.02e-05	0.00032	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—testicular cancer	1.01e-05	0.000317	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—testicular cancer	1e-05	0.000317	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—testicular cancer	1e-05	0.000317	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—testicular cancer	1e-05	0.000316	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—testicular cancer	9.99e-06	0.000315	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—testicular cancer	9.97e-06	0.000314	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—testicular cancer	9.9e-06	0.000312	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—testicular cancer	9.9e-06	0.000312	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—testicular cancer	9.9e-06	0.000312	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—testicular cancer	9.84e-06	0.00031	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	9.84e-06	0.00031	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—testicular cancer	9.78e-06	0.000308	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—testicular cancer	9.78e-06	0.000308	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—testicular cancer	9.77e-06	0.000308	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—testicular cancer	9.59e-06	0.000302	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—testicular cancer	9.53e-06	0.0003	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—testicular cancer	9.49e-06	0.000299	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—testicular cancer	9.47e-06	0.000298	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—testicular cancer	9.45e-06	0.000298	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—testicular cancer	9.43e-06	0.000297	CcSEcCtD
Vinorelbine—Pain—Methotrexate—testicular cancer	9.38e-06	0.000296	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.35e-06	0.000295	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—testicular cancer	9.31e-06	0.000294	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—testicular cancer	9.3e-06	0.000293	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—testicular cancer	9.27e-06	0.000292	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—testicular cancer	9.22e-06	0.000291	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—testicular cancer	9.21e-06	0.00029	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—testicular cancer	9.15e-06	0.000288	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—testicular cancer	9.05e-06	0.000285	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—testicular cancer	9.03e-06	0.000285	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—testicular cancer	8.97e-06	0.000283	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—testicular cancer	8.92e-06	0.000281	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—testicular cancer	8.87e-06	0.00028	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—testicular cancer	8.86e-06	0.000279	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—testicular cancer	8.85e-06	0.000279	CcSEcCtD
Vinorelbine—Pain—Epirubicin—testicular cancer	8.77e-06	0.000277	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—testicular cancer	8.77e-06	0.000277	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—testicular cancer	8.71e-06	0.000275	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—testicular cancer	8.67e-06	0.000273	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—testicular cancer	8.67e-06	0.000273	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.65e-06	0.000273	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—testicular cancer	8.52e-06	0.000269	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—testicular cancer	8.46e-06	0.000267	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—testicular cancer	8.46e-06	0.000267	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—testicular cancer	8.39e-06	0.000265	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—testicular cancer	8.25e-06	0.00026	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.2e-06	0.000258	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—testicular cancer	8.18e-06	0.000258	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—testicular cancer	8.15e-06	0.000257	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—testicular cancer	8.12e-06	0.000256	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—testicular cancer	8.12e-06	0.000256	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—testicular cancer	8.11e-06	0.000256	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—testicular cancer	8.11e-06	0.000256	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—testicular cancer	8.08e-06	0.000255	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—testicular cancer	7.87e-06	0.000248	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—testicular cancer	7.82e-06	0.000247	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—testicular cancer	7.76e-06	0.000245	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—testicular cancer	7.76e-06	0.000245	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—testicular cancer	7.56e-06	0.000238	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—testicular cancer	7.54e-06	0.000238	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—testicular cancer	7.5e-06	0.000237	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—testicular cancer	7.5e-06	0.000237	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—testicular cancer	7.5e-06	0.000237	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—testicular cancer	7.36e-06	0.000232	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—testicular cancer	7.26e-06	0.000229	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—testicular cancer	7.25e-06	0.000229	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—testicular cancer	7.02e-06	0.000221	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—testicular cancer	6.99e-06	0.000221	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—testicular cancer	6.97e-06	0.00022	CcSEcCtD
Vinorelbine—Rash—Methotrexate—testicular cancer	6.91e-06	0.000218	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—testicular cancer	6.91e-06	0.000218	CcSEcCtD
Vinorelbine—Headache—Methotrexate—testicular cancer	6.87e-06	0.000217	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—testicular cancer	6.81e-06	0.000215	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—testicular cancer	6.78e-06	0.000214	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—testicular cancer	6.72e-06	0.000212	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—testicular cancer	6.52e-06	0.000206	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—testicular cancer	6.51e-06	0.000205	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—testicular cancer	6.5e-06	0.000205	CcSEcCtD
Vinorelbine—Rash—Epirubicin—testicular cancer	6.47e-06	0.000204	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—testicular cancer	6.46e-06	0.000204	CcSEcCtD
Vinorelbine—Headache—Epirubicin—testicular cancer	6.43e-06	0.000203	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—testicular cancer	6.28e-06	0.000198	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—testicular cancer	6.09e-06	0.000192	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—testicular cancer	6.04e-06	0.00019	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—testicular cancer	5.99e-06	0.000189	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—testicular cancer	5.98e-06	0.000189	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—testicular cancer	5.95e-06	0.000188	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—testicular cancer	5.64e-06	0.000178	CcSEcCtD
